Get the Stockscreener App
3.04
0.66%
0.02
After Hours:
2.95
-0.09
-2.96%
Alector Inc stock is traded at $3.04, with a volume of 1.16M.
It is up +0.66% in the last 24 hours and up +10.55% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$3.02
Open:
$3
24h Volume:
1.16M
Relative Volume:
0.99
Market Cap:
$307.69M
Revenue:
$100.56M
Net Income/Loss:
$-119.05M
P/E Ratio:
-2.4715
EPS:
-1.23
Net Cash Flow:
$-231.16M
1W Performance:
-4.40%
1M Performance:
+10.55%
6M Performance:
+220.00%
1Y Performance:
-36.67%
1-Day Range:
$2.905
$3.07
1-Week Range:
$2.905
$3.25
52-Week Range:
$0.87
$6.14
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
3.04 | 305.66M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Combining machine learning predictions for Alector Inc.2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Is Alector Inc. stock a defensive play in 2025Trade Analysis Report & Weekly Momentum Picks - newser.com
Will Alector Inc. stock attract ESG investorsSwing Trade & Risk Managed Investment Strategies - newser.com
Why Alector Inc. stock attracts global investorsJuly 2025 Pullbacks & High Yield Stock Recommendations - newser.com
Will Alector Inc. stock maintain dividend yieldTrade Exit Summary & AI Powered Buy/Sell Recommendations - newser.com
Analyzing drawdowns of Alector Inc. with statistical toolsShort Setup & Weekly High Conviction Trade Ideas - newser.com
What MACD and RSI say about Alector Inc.Market Rally & Expert-Curated Trade Recommendations - newser.com
Is Alector Inc. stock supported by strong cash flowsWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Custom watchlist performance reports with Alector Inc.Trade Analysis Report & Proven Capital Preservation Methods - newser.com
What recovery options are there for Alector Inc.July 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com
Is now a turning point for Alector Inc.Insider Buying & Step-by-Step Swing Trade Plans - newser.com
4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals - Benzinga
Key metrics from Alector Inc.’s quarterly data2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com
Chart overlay techniques for tracking Alector Inc.2025 Fundamental Recap & Community Driven Trade Alerts - newser.com
Can Alector Inc. stock maintain operating marginsJuly 2025 Big Picture & Growth-Oriented Investment Plans - newser.com
Is Alector Inc. stock positioned for long term growth2025 Major Catalysts & High Conviction Trade Alerts - newser.com
Reversal indicators forming on Alector Inc. stockTake Profit & Risk Controlled Stock Pick Alerts - newser.com
Ranking Alector Inc. among high performing stocks via toolsQuarterly Portfolio Review & Consistent Growth Equity Picks - newser.com
Alector's (ALEC) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
3 Promising Penny Stocks With Market Caps Under $400M - simplywall.st
Alector Stock: Unlocking Middle Aged Dementia (NASDAQ:ALEC) - Seeking Alpha
Alector, Inc. (NASDAQ:ALEC) is a favorite amongst institutional investors who own 70% - Yahoo
Is Alector Inc. stock bottoming outWeekly Trend Recap & Low Risk Entry Point Guides - newser.com
Why Alector Inc. (0Z2) stock remains stablePortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com
Cantor Fitzgerald Forecasts Weaker Earnings for Alector - Defense World
Cantor Fitzgerald Predicts Lower Earnings for Alector - MarketBeat
Why analysts remain bullish on Alector Inc. stock2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Will INFRONT-3 Data Bring Alector To The Forefront Of Frontotemporal Dementia Treatment? - RTTNews
Alector Inc Stock Analysis and ForecastReal Estate Investment Trusts & Plan Every Trade With Controlled Risk - earlytimes.in
What drives Alector Inc stock priceEvening Star Patterns & Exceptional Growth Investment - earlytimes.in
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alector Inc Stock (ALEC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Berkley Neil Lindsay | Principal Financial Officer |
Sep 02 '25 |
Sale |
2.50 |
15,842 |
39,554 |
346,570 |
| Kenkare-Mitra Sara | President and Head of R&D |
Sep 02 '25 |
Sale |
2.50 |
23,638 |
59,019 |
543,339 |
| Rosenthal Arnon | Chief Executive Officer |
Sep 02 '25 |
Sale |
2.50 |
51,562 |
128,740 |
2,350,220 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):